Treatment
Medication clinical trials
We’re tracking 7,140 recruiting studies that include Medication, each written for real people, not researchers, below.
Recruiting studies
- NCT07035535Enrolling by invitation
Using genetic tests to predict antibiotic resistance in lung infections
This trial looks at whether a special genetic test (tNGS) can predict which antibiotics will work for bacteria causing lung infections. It may help doctors choose the right treatment faster.
Nanjing, JiangsuAges 18 years+ - NCT07039292Enrolling by invitation
Can e-cigarettes help reduce smoking?
This study tests whether e-cigarettes can help people who smoke but have not wanted to use other treatments. If you currently smoke and have declined traditional options like nicotine patches or quitlines, you may be able to join.
Charleston, South CarolinaAges 21 years+ - NCT07037472Recruiting
Imaging calcium deposits in dermatomyositis patients
This study uses a special imaging technique (photoacoustic/ultrasound) to look at calcium deposits under the skin in people with dermatomyositis. It aims to find patterns that help doctors understand the condition and track how well treatments work.
BeijingAges 18–80 - NCT07036952Enrolling by invitation
Omega-3 for metabolic syndrome in PCOS
This trial tests if adding omega-3 supplements to standard care helps women with PCOS who also have metabolic syndrome. It may offer a natural way to improve associated health issues.
Dhaka, BsmmuAges 18–36 - NCT07041450Recruiting
Screening for Alzheimer's treatment using digital tests and blood tests
This study is testing whether simple digital memory tests and blood tests can help find people who might qualify for anti-amyloid treatments (medications that target Alzheimer's-related proteins). It aims to make screening easier and faster, without needing a spinal tap or PET scan.
Greenfield Park, QuebecAges 55–90 - NCT07034391RecruitingPhase 2
PD-1 inhibitor with denosumab and chemo for advanced lung cancer
This trial tests a combination of an immunotherapy drug (PD-1 inhibitor), a bone-strengthening drug (denosumab), and chemotherapy for people with advanced or spread non-squamous non-small cell lung cancer that does not have certain genetic changes. The goal is to see if this combination helps shrink tumors and control the disease.
Shenyang, LiaoningAges 18–75 - NCT07040098RecruitingPhase 2
Optimizing immunotherapy with chemo-radiation for rectal cancer
This trial tests combining immunotherapy with standard chemotherapy and radiation before surgery for locally advanced rectal cancer. It aims to see if this approach can improve outcomes for patients whose tumors have certain genetic features (pMMR or MSS).
BeijingAges 18–75 - NCT07034742RecruitingEarly Phase 1
MRD testing after stomach cancer surgery
This study looks at whether a blood test for leftover cancer cells (called MRD) after stomach cancer surgery can help guide treatment. It is for people with a certain type of stomach cancer that has spread to nearby tissues but not to distant organs, and who are having surgery as their first treatment.
BeijingAges 18–75 - NCT07037563Recruiting
AI chatbot for managing diabetes, blood pressure, or cholesterol
This trial is testing a new AI chatbot that helps people in Hong Kong manage their health conditions like high blood sugar, high blood pressure, or high cholesterol. If you take medication for one of these conditions or care for someone who does, you may be able to join.
Hong KongAges 18 years+ - NCT06992622Recruiting
Youth spine and vision health study
This study is following a group of young people with scoliosis to better understand how their spine and vision change over time. It may help you learn more about your condition and contribute to future care.
Wenzhou, ZhejiangAges 6–17 - NCT01793168Recruiting
Rare disease registry and history study
This study keeps a registry (a structured list) of people with rare diseases and may also track how the condition changes over time. It can help researchers better understand rare illnesses and find gaps in care, which may improve future treatments.
Sioux Falls, South DakotaAges Any age - NCT04247685Recruiting
MRI-safe heart rhythm test in people with atrial fibrillation
This trial checks whether a specific MRI-safe 12-lead heart recording (ECG) works correctly during MRI scans. It may help improve how doctors monitor heart rhythm while imaging, especially for people with atrial fibrillation.
Toronto, OntarioAges 18–90 - NCT07024667Recruiting
Laser treatment study for vaginal atrophy symptoms
This trial tests a carbon dioxide laser (FemiLift) to see if it can help women with vaginal dryness, burning, itching, or pain during sex caused by menopause. It aims to improve symptoms without hormones.
HaderaAges 45–75 - NCT06816836Recruiting
Measuring leg muscle mass to predict hospital stay after cancer surgery
This study uses ultrasound to measure leg muscle mass before surgery for gynecologic cancers, to see if it can predict how long you'll need to stay in the hospital after the operation.
Kolkata, West BengalAges 50–99 - NCT07026877Recruiting
Stent graft study for abdominal aortic aneurysm
This study tests a special stent graft (a fabric tube placed inside the artery) that has openings (fenestrations) to fit around other blood vessels. It is for people with an abdominal aortic aneurysm who need a custom-fit repair to keep blood flow normal.
Colorado Springs, ColoradoAges 18 years+ - NCT06995157Recruiting
HPV infections and vaccine attitudes in Slovenian women
This observational study looks at HPV infections and women's views about the HPV vaccine in Slovenia. It aims to understand the characteristics of HPV infections and attitudes toward vaccination after the vaccine became available.
Ljubljana, Municipality of DomžaleAges Up to 35 years - NCT05448833Recruiting
Testing a wireless sensor to monitor left heart pressure
This study tests whether a small wireless sensor can safely measure and track pressure in the left upper heart chamber in people with advanced chronic heart failure. It may help the care team better understand pressure changes that are linked to fluid buildup and symptoms, alongside your usual heart medicines.
Petah TikvaAges 22–88 - NCT05712824Recruiting
Device to measure left-heart pressure in advanced heart failure
This trial tests a wirelessly implanted device that measures pressure in the left upper heart chamber (left atrial pressure) in people with advanced heart failure. By tracking that pressure, researchers hope to better understand disease status and guide care.
Tbilisi, GeorgiaAges 22–88 - NCT06157996RecruitingPhase 2
Lenvatinib, Tislelizumab, and CapeOX for advanced stomach cancer
This trial tests a combination of three drugs (lenvatinib, tislelizumab, and CapeOX chemotherapy) as the first treatment for advanced stomach or gastroesophageal junction cancer that is PD-L1 positive and has a low TMEscore. The goal is to see if this combination helps control the cancer better than standard treatments.
Guangzhou, GuangdongAges 18 years+ - NCT07026786Recruiting
Mindfulness for recovery after colorectal surgery
This study tests whether adding mindfulness sessions to your standard recovery plan helps you heal better after bowel surgery. You'll use a phone or tablet app to guide your mindfulness practice during your hospital stay.
Cleveland, OhioAges 18 years+ - NCT07024199RecruitingPhase 4
Pain relief for children with acute pancreatitis
This trial compares three common pain relievers (paracetamol, ibuprofen, and metamizole) to see which works best for children with acute pancreatitis. It aims to help your child feel better faster with fewer side effects.
WarsawAges 3–18 - NCT07032506Recruiting
Stent placement after uterine septum surgery
This trial tests whether placing a small stent in the uterus after surgery to remove a uterine septum (a wall of tissue dividing the uterus) can help improve healing and future pregnancy chances. It is for people who have a septum that covers at least half of the uterine cavity.
Little Rock, ArkansasAges 18 years+ - NCT07032818Recruiting
Helping patients go home safely after a hospital stay
This study tests a program to help patients with limited English get the support they need when leaving the hospital. If you speak Spanish, Haitian Creole, Portuguese, Cape Verdean, or Vietnamese and are being discharged home from Boston Medical Center, you may be able to join.
Boston, MassachusettsAges 18 years+ - NCT07025226RecruitingEarly Phase 1
Combination drugs and vaccine for glioma with remaining tumor
This trial tests a combination of several drugs and a vaccine to see if they can help treat glioma that has not gone away with previous treatment. It is for people whose tumors have certain gene changes and who still have some tumor remaining after standard therapy.
Rochester, MinnesotaAges 18 years+
Common questions
- Are there clinical trials studying Medication?
- Yes. Clin2 currently lists 7,140 recruiting studies that include Medication, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Medication trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Medication an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Medication or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.